Turkish Journal of Nephrology
Case Report

Development of Reversible Posterior Leukoencephalopathy Syndrome after Cyclophosphamide Treatment in a Patient with Lupus Nephritis

1.

Pamukkale Üniversitesi, Tıp Fakültesi, Nefroloji Bilim Dalı, Denizli, Türkiye

2.

Pamukkale Üniversitesi, Tıp Fakültesi Nöroloji Anabilim Dalı, Denizli, Türkiye

3.

Pamukkale Üniversitesi, Tıp Fakültesi, Radyoloji Anabilim Dalı, Denizli, Türkiye

4.

Pamukkale Üniversitesi, Tıp Fakültesi, Patoloji Anabilim Dalı, Denizli, Türkiye

5.

Pamukkale Üniversitesi, Tıp Fakültesi, Romatoloji Bilim Dalı, Denizli, Türkiye

6.

Pamukkale Üniversitesi, Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Denizli, Türkiye

Turkish J Nephrol 2011; 20: 104-107
DOI: 10.5262/tndt.2011.1001.19
Read: 1349 Downloads: 786 Published: 06 February 2019

Renal involvement in systemic lupus erythematosus is a frequent and serious complication that significantly increases morbidity and mortality. Despite all studies and usage of new drugs, treatment of lupus nephritis continues to be a problem. Diffuse proliferative lupus nephritis has a poor prognosis and aggressive treatment must be undertaken. Cyclophosphamide is commonly used in treatment despite its side effects. Reversible posterior leucoencephalopathy syndrome is a clinico-radiological syndrome manifested by blood pressure elevation, headache, visual disturbances, confusion, seizures and sometimes focal neurological signs that can develop due to usage of cytotoxic drugs. We present a case of lupus nephritis in which reversible posterior leucoencephalopathy syndrome developed after intravenous cyclophosphamide administration and recovered spontaneously by symptomatic treatment in this article.

Files
EISSN 2667-4440